Combating resistance: The case for a global antibiotics treaty

Public Health Ethics

Volumn 3, Issue 1, 2010, Pages 13-22

  Anomaly, Jonny ^a  

^a TULANE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; BACTERIAL INFECTION; CLIMATE CHANGE; DRUG MARKETING; HEALTH CARE COST; HEALTH CARE POLICY; HUMAN; MEDICAL ETHICS; OZONE DEPLETION; PRIORITY JOURNAL; REVIEW; WELFARE; WORLD HEALTH ORGANIZATION;

EID: 77953367332     PISSN: 17549973     EISSN: 17549981     Source Type: Journal    
DOI: 10.1093/phe/phq001     Document Type: Review

References (34)

1. Andersson, D. and Levin, B. (1999). The Biological Cost of Antibiotic Resistance. Current Opinion in Microbiology, 2, 489-493.
2. Anomaly, J. (2009). Harm to Others: The Social Cost of Antibiotics in Agriculture. Journal of Agricultural and Environmental Ethics, 22, 423-435.
3. Barrett, S. (1999). Montreal vs. Kyoto. In Kaul, I., Grunberg, I. and SternM. (eds.), Global Public Goods. New York, NY: Oxford University Press.
4. Barrett, S. (2007).WhyCooperate? The Incentive to Supply Global Public Goods. Oxford, UK: Oxford University Press.
5. Camerer, C. (2003). Behavioral Game Theory: Experiments in Strategic Interaction. Princeton,NJ:Princeton University Press.
6. Coase, R. (1960).The Problem of SocialCost. The Journal of Law and Economics, 3, 1-44.
7. Feinberg, J. (1987). Harm to Others: The Moral Limits of the Criminal Law. Oxford, UK: University Press: Oxford, UK.
8. Gaus, G. (1999). Social Philosophy. London, UK: M.E. Sharpe Publishing.
9. Kades, E. (2005). Preserving a Precious Resource: Rationalizing the Use of Antibiotics. Northwestern University Law Review, 99, 611-675.
10. Kaul, I.,Grunberg, I. and Stern,M. (1999). Introduction. Global PublicGoods.NewYork,NY:OxfordUniversity Press.
11. LaFollette, H. (1980). Licensing Parents. Philosophy and Public Affairs, 9, 182-187.
12. Laxminarayan, R. (2003). On the Economics of Resistance. In Laxminarayan, R. (ed.), Battling Resistance to Antibiotics and Pesticides.Washington, DC: Resources for the Future.
13. Laxminarayan, R. (2007). Antibiotic Resistance: TheUnfolding Crisis. In Laxminarayan, R. and Malani, A. (eds.), Extending theCure.Washington,DC: Resources for the Future.
14. Levy, S. (1998). The Challenge of Antibiotic Resistance. Scientific American, 1998, 46-53. March.
15. Levy, S. (2002). The Antibiotic Paradox. Cambridge, MA: Perseus Publishing.
16. Gorbach, S. (2001). Antimicrobial Use in Animal Feed- Time to stop. New England Journal of Medicine, 345, 169-178.
17. Mill, J. S. (2002). On Liberty. NewYork, NY:TheModern Library.
18. Nathan, C. (2004). Antibiotics at the Crossroads. Nature, 431, 899-902.
19. Pigou, A. C. (1962). The Economics of Welfare. 4th ed. New York, NY: St. Martin's Press.
20. Rudholm, N. (2002). Economic Implications of Antibiotic Resistance in a Global Economy. Journal ofHealth Economics, 21, 1071-1083.
21. Sachs, J. S. (2007). Good Germs, Bad Germs: Health and Survival in a Bacterial World. New York, NY:Hill and Wang.
22. Sachs, J. S. (2008). DNA Pollution May Be Spawning Killer Microbes. Discover Magazine, 15 August 2009. http://discovermagazine.com/2008/mar/14- dnapollution- may-be-spawning-killer-microbes.
23. Salyers, A. and Amabile-Cuevas, C. (1997). Minireview: Why are Antibiotic Resistance Genes so Resistant to Elimination? Antimicrobial Agents and Chemotherapy, 41, 2321-2325.
24. Sandler, T. (1997). Global Challenges: An Approach to Environmental, Political, and Economic Problems. Cambridge, UK: Cambridge University Press.
25. Sandler, T. (2004). Global Collective Action. Cambridge, UK: Cambridge University Press.
26. Selgelid, M. J. (2007). Ethics and Drug Resistance. Bioethics, 19, 272-289.
27. Selgelid, M. J. (2009). A Moderate Pluralist Approach to Public Health Policy and Ethics. Public Health Ethics, 2, 195-205.
28. Sinnott-Armstrong,W. (2005). It's NotMy Fault: Global Warming and Individual Obligations. In Sinnott- Armstrong, W. and Howarth, R. (eds.), Perspectives on Climate Change. Stamford, CT: JAI Press.
29. Smith, R. and Coast, J. (1997). Controlling Antimicrobial Resistance: a Proposed Transferable Permit Market System. Health Policy, 43, 219-232.
30. Smith, R. and Coast, J. (2004). Antimicrobial Drug Resistance. In Smith, R., Beaglehole, Ro, Woodward, D. and Drager, N. (eds.), Global Public Goods for Health. Oxford, UK: Oxford University Press.
31. Stiglitz, J. (1999). Knowledge as a Global Public Good. In Kaul, I., Grunberg, I. and Stern, M. (eds.), Global Public Goods. New York, NY: Oxford University Press.
32. Waters, C. and Bassler, B. (2005).QuorumSensing: Cellto- Cell Communication in Bacteria. Annual Review of Cell and Developmental Biology, 21, 319-346.
33. WHO( 2001a). Antibiotic Resistance: Synthesis of Recommendations by Expert Policy Groups. Geneva, Switzerland: WHO.
34. WHO(2001b). Global Strategy for Containment of Antimicrobial Resistance. Geneva, Switzerland: WHO.